Logo image of SGYP

SYNERGY PHARMACEUTICALS DEL (SGYP) Stock Fundamental Analysis

USA - NASDAQ:SGYP -

0.03
-0.03 (-52%)
Last: 3/7/2019, 10:32:13 PM
0.0512
+0.02 (+70.67%)
After Hours: 3/7/2019, 10:32:13 PM
No Fundamental Analysis report for SGYP not available.

SYNERGY PHARMACEUTICALS DEL

NASDAQ:SGYP (3/7/2019, 10:32:13 PM)

After market: 0.0512 +0.02 (+70.67%)

0.03

-0.03 (-52%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners0.45%
Ins Owner Change0%
Market Cap7.44M
Revenue(TTM)41.34M
Net Income(TTM)-137312000
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)0%
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.18
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA -0.61
EPS(TTM)-0.59
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.17
BVpS-0.39
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -165.36%
ROE 142.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -327.83%
PM (TTM) -332.11%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.38
Altman-Z -21.8
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.36%
EPS Next Y47.06%
EPS Next 2Y53.16%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)457.21%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%121.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

SYNERGY PHARMACEUTICALS DEL / SGYP FAQ

Can you provide the ChartMill fundamental rating for SYNERGY PHARMACEUTICALS DEL?

ChartMill assigns a fundamental rating of 3 / 10 to SGYP.


Can you provide the valuation status for SYNERGY PHARMACEUTICALS DEL?

ChartMill assigns a valuation rating of 0 / 10 to SYNERGY PHARMACEUTICALS DEL (SGYP). This can be considered as Overvalued.


How profitable is SYNERGY PHARMACEUTICALS DEL (SGYP) stock?

SYNERGY PHARMACEUTICALS DEL (SGYP) has a profitability rating of 4 / 10.


Can you provide the dividend sustainability for SGYP stock?

The dividend rating of SYNERGY PHARMACEUTICALS DEL (SGYP) is 0 / 10 and the dividend payout ratio is 0%.